Daxor (DXR) vs SkinHealth Systems (SKIN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Daxor (DXR) has outperformed SkinHealth Systems (SKIN) over the past year, losing 20.0% versus a loss of 66.5%. Over five years, DXR leads with a -7.0% price change compared with -97.8% for SKIN. SkinHealth Systems is the larger company by market cap ($69.9 million vs $61.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DXR | SKIN |
|---|---|---|
| Share price | $10.49 | $0.5374 |
| Market cap | $61.21M | $69.94M |
| 1-day change | +0.24% | -5.54% |
| YTD return | -29.08% | -59.07% |
| 1-year return | -20.03% | -66.54% |
| 5-year return | -7.02% | -97.78% |
| P/E ratio (TTM) | 9.53 | — |
| Forward P/E | — | 2.83 |
| EPS (TTM) | $1.10 | $-0.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.76 | $1.74 |
| 52-week low | $8.56 | $0.5019 |
| Distance from 52-week high | -28.96% | -69.11% |
| Analyst consensus | none | none |
| Avg. price target upside | +90.75% | +84.22% |
| Average volume | 17.27K | 489.80K |
| Shares outstanding | 5.84M | 130.14M |
| Employees | — | 613 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DXR has outperformed SKIN by 46.5 percentage points over the past year.
About Daxor
DXR stock →Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.
Health Care · Medical/Dental Instruments
About SkinHealth Systems
SKIN stock →SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums.
Health Care · Medical/Dental Instruments · 613 employees
DXR vs SKIN FAQ
Which is bigger, Daxor or SkinHealth Systems?
SkinHealth Systems (SKIN) is larger, with a market capitalization of $69.94M compared with $61.21M for Daxor (DXR).
Which stock has performed better over the past year, DXR or SKIN?
DXR returned -20.03% over the past 12 months, compared with -66.54% for SKIN (price return, excluding dividends). Past performance does not predict future results.
Are Daxor and SkinHealth Systems in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.